doi:10.3969/j.issn.1673-8640.2015.12.014

Abstract

CLC Number:

R446.11

Figures/Tables 4

References 15

[1]	SPILLER F,COSTA C,SOUTO FO,et al.Inhibition of neutrophil migration by hemopexin leads to increased mortality due to sepsis in mice[J]. Am J Respir Crit Care Med,2011,183(7):922-931.
[2]	边毓尧,寿松涛. 脓毒症患者早期血浆皮质醇水平变化及其临床意义研究[J]. 中国全科医学,2013,16(9):1026-1029.
[3]	崔惠芬,石波,尹润彬. 血乳酸清除率与APACHEⅡ评分在感染性休克患者中的相关性探讨[J]. 中国医药导报,2014,11(6): 26-28.
[4]	姚咏明,盛志勇,林洪远,等. 2001年国际脓毒症定义会议关于脓毒症诊断的新标准[J]. 中国危重病急救医学,2006,18(11):645.
[5]	骆晓攀,方俊标,陈龙,等. APACHE Ⅱ、MODS、SOFA和LODS评分系统对重症急性胰腺炎预后评估的比较[J]. 医学研究杂志,2012,41(7):104-108.
[6]	李晓爽,吕洪敏,李凤惠,等. MELD、MELD-Na、SOFA评分系统对肝衰竭短期预后的价值[J]. 天津医药,2012,40(9):902-904.
[7]	殷胜禄. SOFA评分联合降钙素原在脓毒症早期诊断及预后应用[J]. 中华医院感染学杂志,2013,23(11):2536-2538.
[8]	程鹏雁,马渝,陶杨,等. 脓毒症患者入ICU时血浆血小板活化因子水平与病情严重程度的相关性分析[J]. 重庆医科大学学报,2014,39(7):1027-1031.
[9]	SPILLER F,CARLOS D,SOUTO FO,et al.α1-acid glycoprotein decreases neutrophil migration and increases susceptibility to sepsis in diabetic mice[J]. Diabetes,2012,61(6):1584-1591.
[10]	梅春霞,刘娟,徐智,等. APACHEIⅡ评分和降钙素原对肺部感染预后的预测作用[J]. 第三军医大学学报,2014,36(8):802-805.
[11]	海祺旻,沈德良,刘琮琳,等. 血小板活化因子在各型冠心病中的表达及与冠脉Gensini积分的相关性研究[J]. 中国全科医学,2014,17(7):788-791.
[12]	李瀛,余丹,侯丹,等. 局部亚低温治疗进展性脑卒中对血浆血小板活化因子水平的影响与患者预后的关系[J]. 中华临床医师杂志:电子版,2012,6(16):4865-4866.
[13]	MAZEREEUW G,HERRMANN N,BENNETT SA,et al.Platelet activating factors in depression and coronary artery disease: a potential biomarker related to inflmmatory mechanisms and neurodegeneration[J]. Neurosci Biobehav Rev,2013,37(8):1611-1621.
[14]	雷有萍. 血浆血小板活化因子水平与感染性重症监护病房患者病情程度及预后状况的关系研究[J]. 上海医药,2014,36(17):31-33.
[15]	程鹏雁. 脓毒症患者血浆血小板活化因子与皮质醇水平相关性及临床评估意义[D].重庆:重庆医科大学,2014.

组别	例数	APACHEⅡ评分	SOFA评分	PAF(ng/ L)
正常对照组	20	0	0	824.05±62.75
脓毒症组	29	12.38±3.75^*	7.52±2.33^*	1 088.72±98.16^*
严重脓毒症组	20	15.85±4.22^*#	11.86±3.05^*#	1 264.73±108.44^*#
脓毒性休克组	19	19.26±5.17^*#△	14.25±4.25^*#△	1 399.76±124.75^*#△
F值		22.155	18.356	102.338
P值		0.005	0.008	0.000

组别	例数	APACHEⅡ评分	SOFA评分	PAF(ng/ L)
正常对照组	20	0	0	824.05±62.75
脓毒症组	29	12.38±3.75^*	7.52±2.33^*	1 088.72±98.16^*
严重脓毒症组	20	15.85±4.22^*#	11.86±3.05^*#	1 264.73±108.44^*#
脓毒性休克组	19	19.26±5.17^*#△	14.25±4.25^*#△	1 399.76±124.75^*#△
F值		22.155	18.356	102.338
P值		0.005	0.008	0.000

组别	例数	APACHEⅡ评分	SOFA评分	FAP水平(ng/ L)
正常对照组	20	0	0	824.05±62.75
存活组	40	15.06±4.14^*	11.37±3.21^*	1 285.55±109.25^*
死亡组	28	18.75±5.05^*	14.05±4.17^*	1 379.26±126.38^*

组别	例数	APACHEⅡ评分	SOFA评分	FAP水平(ng/ L)
正常对照组	20	0	0	824.05±62.75
存活组	40	15.06±4.14^*	11.37±3.21^*	1 285.55±109.25^*
死亡组	28	18.75±5.05^*	14.05±4.17^*	1 379.26±126.38^*

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 4

References 15

Related Articles 15

Recommended Articles

Metrics

[1]	DENG Chenxia, MEI Yanping, ZHANG Xia, HUANG Baoshan, TIAN Dan, CAO Mengting, HU Yongqi, LIN Yongping, TIAN Lijun. Depolymerization effect of optical platelet count on reversible platelet aggregation after blood collection [J]. Laboratory Medicine, 2023, 38(11): 1087-1090.
[2]	LU Tingyan, GU Danfeng, WANG Yahong, GE Yafang, YANG Haiou. Evaluation of vaginal secretion routine determination modes and review criteria analysis [J]. Laboratory Medicine, 2023, 38(11): 1091-1097.
[3]	. [J]. Laboratory Medicine, 2023, 38(11): 1098-1100.
[4]	. [J]. Laboratory Medicine, 2023, 38(10): 983-986.
[5]	. [J]. Laboratory Medicine, 2023, 38(9): 901-904.
[6]	. [J]. Laboratory Medicine, 2023, 38(9): 905-908.
[7]	CHENG Xu, YANG Cunqing, PANG Bo, GU Chun, HOU Xueyun, FEI Jiaxin, WU Min, LI Jun, LIU Guijian. Number and activity of peripheral blood eosinophils in obese people [J]. Laboratory Medicine, 2023, 38(9): 855-859.
[8]	LEI Jing, MAN Qiuhong, ZHAO Renjia, ZHANG Tiejun, JIANG Yanfeng, XU Kelin, SUO Chen, CHEN Xingdong. Elevated red blood cell distribution width increasing the risk of heart failure：a cohort study based on the UK Biobank [J]. Laboratory Medicine, 2023, 38(9): 860-864.
[9]	DUAN Lili, JIANG Chang, ZHOU Dongmei. Role of PLR in ankylosing spondylitis patients with positive antinuclear antibody [J]. Laboratory Medicine, 2023, 38(7): 669-674.
[10]	XIA Yanyan, XIA Yongquan, SONG Guanghao, XIA Mao. Role of coagulation-related monitoring indicators in the course of rivaroxaban anticoagulation for acute venous thromboembolism in elderly patients [J]. Laboratory Medicine, 2023, 38(5): 475-478.
[11]	CHEN Yi, WANG Jia, XU Zhiwei, ZHAI Yaping, XUAN Weixia. Effects of different anticoagulants on phagocytosis，activation and apoptosis of in vitro neutrophil function [J]. Laboratory Medicine, 2023, 38(5): 479-483.
[12]	YANG Liyuan, DAI Wanqin, WANG Xiaotong, LOU Xiaoli, WANG Yue, HOU Yanqiang. Effect of peripheral blood neutrophils on interferon-gamma release assay of Mycobacterium tuberculosis [J]. Laboratory Medicine, 2023, 38(5): 484-488.
[13]	. [J]. Laboratory Medicine, 2023, 38(5): 502-504.
[14]	. [J]. Laboratory Medicine, 2023, 38(1): 69-72.
[15]	XIE Yuan, YI Wanwan, SHI Qiuyuan, LÜ Zhongwei, LIU Jin. Clinical value of thromboelastography and conventional coagulation tests in evaluating coagulation status of colon cancer and colon polyps [J]. Laboratory Medicine, 2022, 37(11): 1007-1011.